These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"]. Hanaki H Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058 [No Abstract] [Full Text] [Related]
4. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections]. Fedulov D; Mihalache DG Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725 [No Abstract] [Full Text] [Related]
5. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
6. [Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?]. Muñoz Bellido JL; García-Rodríguez JA Rev Esp Quimioter; 2006 Dec; 19(4):313-6. PubMed ID: 17235398 [No Abstract] [Full Text] [Related]
8. The effects of vancomycin and beta-lactam antibiotics on vancomycin-resistant Staphylococcus aureus. Haraga I; Nomura S; Nagayama A N Engl J Med; 1999 Nov; 341(21):1624. PubMed ID: 10577134 [No Abstract] [Full Text] [Related]
9. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Aritaka N; Hanaki H; Cui L; Hiramatsu K Antimicrob Agents Chemother; 2001 Apr; 45(4):1292-4. PubMed ID: 11257050 [TBL] [Abstract][Full Text] [Related]
10. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Sieradzki K; Roberts RB; Haber SW; Tomasz A N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472 [No Abstract] [Full Text] [Related]
11. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods. Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127 [TBL] [Abstract][Full Text] [Related]
12. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. Kelley PG; Gao W; Ward PB; Howden BP J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus. Tabuchi F; Matsumoto Y; Ishii M; Tatsuno K; Okazaki M; Sato T; Moriya K; Sekimizu K J Antibiot (Tokyo); 2017 Jun; 70(6):771-774. PubMed ID: 28196977 [TBL] [Abstract][Full Text] [Related]
15. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin. Price J; Atkinson S; Llewelyn M; Paul J Clin Infect Dis; 2009 Apr; 48(7):997-8. PubMed ID: 19260820 [No Abstract] [Full Text] [Related]
16. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. Mariani PG; Sader HS; Jones RN J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029 [No Abstract] [Full Text] [Related]
17. hVISA/VISA: diagnostic and therapeutic problems. Szabó J Expert Rev Anti Infect Ther; 2009 Feb; 7(1):1-3. PubMed ID: 19622051 [No Abstract] [Full Text] [Related]
18. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin. Bhat G; Kamath S; Hussain A Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753 [No Abstract] [Full Text] [Related]
19. Susceptibility to manuka honey of Staphylococcus aureus with varying sensitivities to vancomycin. Jenkins R; Wootton M; Howe R; Cooper R Int J Antimicrob Agents; 2012 Jul; 40(1):88-9. PubMed ID: 22580029 [No Abstract] [Full Text] [Related]
20. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]